Robuta

Acute Lymphoblastic Leukemia is a type of cancer where the bone marrow makes an excessive amount of lymphocytes. The disease develops rapidly and creates...

A multicentric study including a greater number of children is needed to increase understanding of the characteristics of childhood acute lymphoblastic...

Antibody-based immunotherapy is increasingly employed to treat acute lymphoblastic leukemia (ALL) patients. Many T-ALL cells express CD38 on their surface,...

B Cell Acute Lymphoblastic Leukemia

A strong predictor of poor outcome in children with acute lymphoblastic leukemia (ALL) is resistance to chemotherapy with glucocorticoids. Such resistance is...

Learn more about Acute Lymphoblastic Leukemia (ALL) and the resources we have available. ||

This study revealed that the recurrent deletion of MAP3K7/CASP8AP2 is associated with SIL-TAL1 fusions and a mature immunophenotype, but not with response to...

Oct 29, 2025 - Published: October 29, 2025Written by: Saul WisniaNolan Young has aspirations of a career in both the Air Force and FBI, and even at age 15 it’s easy to...

The most common childhood cancer is acute lymphoblastic leukemia (ALL). Chemotherapy-associated hematological toxicity is well-known; however, there are few...